Hudson Bay Capital Management LP Blueprint Medicines Corp Transaction History

Hudson Bay Capital Management LP

$21.9 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$73.17 - $99.79 $717,066 - $977,942	9,800 Added 24.5%	49,800 $4.72 Million
Q4 2023 Feb 14, 2024	SELL	$43.96 - $92.84 $7.91 Million - $16.7 Million	-180,000 Reduced 81.82%	40,000 $3.69 Million
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $3.44 Million - $4.84 Million	73,400 Added 50.07%	220,000 $11 Million
Q2 2023 Aug 14, 2023	SELL	$42.2 - $66.37 $7.44 Million - $11.7 Million	-176,400 Reduced 54.61%	146,600 $9.27 Million
Q1 2023 May 16, 2023	BUY	$37.97 - $50.0 $758,716 - $999,100	19,982 Added 6.59%	323,000 $14.5 Million
Q1 2023 May 15, 2023	BUY	$37.97 - $50.0 $3.41 Million - $4.49 Million	89,850 Added 42.15%	303,018 $13.6 Million
Q4 2022 Feb 14, 2023	BUY	$41.06 - $66.48 $7.32 Million - $11.8 Million	178,168 Added 509.05%	213,168 $9.34 Million
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $10 Million - $15.6 Million	-200,900 Reduced 85.16%	35,000 $2.31 Million
Q2 2022 Aug 12, 2022	BUY	$45.23 - $70.15 $7.73 Million - $12 Million	170,900 Added 262.92%	235,900 $11.9 Million
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $3.52 Million - $7.16 Million	65,000 New	65,000 $4.15 Million
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $1.18 Million - $1.45 Million	-12,500 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$80.98 - $109.47 $1.01 Million - $1.37 Million	-12,500 Reduced 50.0%	12,500 $1.29 Million
Q2 2021 Aug 16, 2021	BUY	$82.78 - $101.0 $2.07 Million - $2.53 Million	25,000 New	25,000 $2.2 Million
Q3 2020 Nov 12, 2020	SELL	$66.45 - $92.7 $3.99 Million - $5.56 Million	-60,000 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$57.09 - $79.27 $1.43 Million - $1.98 Million	-25,000 Reduced 29.41%	60,000 $4.68 Million
Q1 2020 May 14, 2020	BUY	$48.11 - $82.22 $1.44 Million - $2.47 Million	30,000 Added 54.55%	85,000 $4.97 Million
Q4 2019 Feb 12, 2020	BUY	$66.73 - $82.59 $3.67 Million - $4.54 Million	55,000 New	55,000 $4.41 Million
Q2 2019 Aug 14, 2019	SELL	$73.54 - $97.8 $1.47 Million - $1.96 Million	-20,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$48.7 - $86.6 $2.19 Million - $3.9 Million	-45,000 Reduced 69.23%	20,000 $1.6 Million
Q3 2018 Nov 14, 2018	SELL	$58.91 - $78.32 $589,100 - $783,199	-10,000 Reduced 13.33%	65,000 $5.07 Million
Q2 2018 Aug 13, 2018	BUY	$60.96 - $101.18 $2.74 Million - $4.55 Million	45,000 Added 150.0%	75,000 $4.76 Million
Q4 2017 Feb 12, 2018	BUY	$62.91 - $88.32 $1.89 Million - $2.65 Million	30,000	30,000 $2.26 Million

Others Institutions Holding BPMC

# of Institutions

350

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$632 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.65M
Shares

$629 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

5.39M
Shares

$510 Million
0.06% of portfolio
Wellington Management Group LLP Boston, MA

3.96M
Shares

$375 Million
0.07% of portfolio
State Street Corp Boston, MA

2.77M
Shares

$262 Million
0.01% of portfolio

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.65B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account